... ENG

Kathleen Pritchard, MD

Founding Editor

Dr. Pritchard is a medical oncologist and clinical trials research scientist. Her areas of interest include multi-center clinical trials; adjuvant, biologic and hormonal therapy for breast cancer; correlative and translational research in breast cancer; banking of tumor, tissue, serum and data; and predictive and prognostic factors in breast cancer.

In 2005, Dr. Pritchard was awarded the O. Harold Warwick Prize for Cancer Control in Canada by the Canadian Cancer Society and the National Cancer Institute of Canada for her work in clinical and translational trials in breast cancer.

As chair of the National Cancer Institute of Canada Clinical Trials Breast Cancer Site Group (now Canadian Cancer Trials Group), Dr. Pritchard has guided the development and performance of multi-center Canadian clinical trials of new therapies for women with breast cancer for more than 25 years.

Her research has included clinical trials and translational approaches in the areas of adjuvant therapy, hormonal therapy, chemotherapy and optimal locoregional therapy for breast cancer. She has also been a member of the team conducting prevention trials comparing tamoxifen and raloxifene.

Dr. Pritchard holds a major leadership role in national and international multi-center clinical trials. She is a frequent consultant for scientific and clinical groups, and a member of scientific advisory boards and independent data monitoring committees for clinical trials worldwide.

Dr. Pritchard is also widely published, including in The New England Journal of Medicine, Journal of the National Cancer Institute, The Journal of Clinical Oncology, The Lancet, and The Lancet Oncology. Dr. Pritchard serves on the editorial boards of the Journal of Clinical Oncology, European Journal of Cancer, The Oncologist, Clinical Breast Cancer and The Breast.

According to Thomson Reuters, Pritchard was one of the most cited researchers in the world in 2014 and 2015.

App - About

oncoXchange.org is the new precision-medicine platform dedicated to transforming medical education and accelerating knowledge translation into clinical practice to improve patient outcomes.

Lead by a world-renowned scientific board, oncoxchange.org Breast Cancer Edition is medcomXchange’s first peer-to-peer, secure digital-health platform and will be followed by editions dedicated to other areas in oncology.

oncoXchange provides leading educational opportunities and facilitates collaboration between researchers and clinicians. We support the scientific community by offering a stage for the next generation of thought leaders to develop.


Editorial Board

As internationally-recognized leaders in the field of cancer research, the members of the oncoXchange.org Editorial Board guide the platform with unparalleled expertise and insight.

Founding Editor

Kathleen Pritchard, MD

Dr. Pritchard is a medical oncologist and clinical trials research scientist. Her areas of interest include multicentre clinical trials; adjuvant, biologic and hormonal therapy for breast cancer; correlative and translational research in breast cancer; banking of tumour, tissue, serum and data; and predictive and prognostic factors in breast cancer. According to Thomson Reuters, Pritchard was one of the most cited researchers in the world in 2014 and 2015.

Read more...

Have a question?

Want to create a group?

Reach us at oncoXchange, the precision-medicine platform.